New Insights into Lung Health and Disease Prevention
PERTH — New findings in respiratory research were unveiled this week at the TSANZSRS 2026 conference, showcasing advancements in understanding lung diseases and potential treatments. Held at the Perth Convention and Exhibition Centre, the event runs from March 27 to 31, featuring significant contributions from early-career researchers.
The conference highlighted a wide array of studies, including those focusing on genomics, chronic obstructive pulmonary disease (COPD), and rare lung conditions. According to the Thoracic Society of Australia and New Zealand (TSANZ), these investigations aim to improve diagnostic methods and patient outcomes.
Innovative Approaches in Respiratory Medicine
Among the featured researchers, Dr Meera Srinivasan presented insights into COPD, emphasising the clinical significance of hyperinflation and expiratory flow limitation. “Understanding these physiological hallmarks can help identify patients at higher risk,” she noted.
In addition, Mrs Bianca Iacopetta shared findings from the PLEASE-3 study, examining bendopnoea in pleural effusion patients. She explained, “Recognising this symptom is crucial for improving clinical care, particularly in assessing walking capacity post-drainage.”
The conference also explored genetic factors in respiratory disease. Dr Dinh Bui discussed the impact of premature birth on lung function, while Associate Professor Gerard Kaiko focused on personalized genomic data for refining diagnoses.
The TSANZSRS 2026 meeting reflects ongoing efforts to advance respiratory medicine through research and innovation. The Thoracic Society continues to support these initiatives, contributing to better lung health outcomes across Australia and New Zealand.
Last updated: 29 June 2026, 12:38 pm
